What antibiotic is recommended for a skin infection after a cut to the finger?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Skin Infection After Finger Cut

For a simple skin infection following a finger cut, oral cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily for 7-10 days is the recommended first-line treatment. 1

Treatment Algorithm

Assess Infection Severity

Mild, uncomplicated infection (no systemic signs):

  • Cephalexin 500 mg orally four times daily is the preferred oral agent for methicillin-susceptible Staphylococcus aureus (MSSA), which causes most simple skin infections 1
  • Dicloxacillin 500 mg orally four times daily is an alternative oral agent of choice for MSSA 1
  • Amoxicillin-clavulanate 875/125 mg twice daily provides broader coverage if mixed flora is suspected 1
  • Treatment duration: 7-10 days 1

For penicillin-allergic patients (non-immediate hypersensitivity):

  • Cephalexin remains appropriate unless there is a history of immediate hypersensitivity reactions (urticaria, angioedema, bronchospasm, anaphylaxis) 1

For penicillin-allergic patients (immediate hypersensitivity):

  • Clindamycin 300-450 mg orally three times daily 1
  • Note: Clindamycin has potential for Clostridioides difficile-associated disease 1

If MRSA is Suspected or Confirmed

Community-acquired MRSA (CA-MRSA) coverage needed when:

  • Patient has failed initial beta-lactam therapy 1
  • Known MRSA colonization or previous MRSA infection 1
  • Systemic toxicity present 1

Oral options for CA-MRSA:

  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily 1
  • Doxycycline 100 mg twice daily (avoid in children <8 years and pregnancy) 1
  • Clindamycin 300-450 mg three times daily (provides coverage for both MRSA and beta-hemolytic streptococci) 1

Severe Infection Requiring IV Therapy

Indications for hospitalization and IV antibiotics:

  • Rapidly progressive infection despite oral antibiotics 1
  • Systemic toxicity (fever, tachycardia, hypotension) 1
  • Immunocompromised host 1
  • Deep tissue involvement or abscess requiring drainage 1

IV antibiotic options:

  • Nafcillin or oxacillin 1-2 g every 4 hours IV for MSSA 1
  • Cefazolin 1 g every 8 hours IV (more convenient than nafcillin, suitable for penicillin allergy except immediate hypersensitivity) 1
  • Vancomycin 15-20 mg/kg/dose every 8-12 hours IV for MRSA 1

Special Considerations

If Contaminated or Dirty Wound

  • Consider broader coverage with amoxicillin-clavulanate to cover mixed aerobic and anaerobic bacteria 1
  • Ensure adequate wound cleaning and debridement 1

Tetanus Prophylaxis

  • Administer tetanus toxoid if not vaccinated within 10 years 1
  • Tdap (tetanus, diphtheria, pertussis) is preferred over Td if not previously given 1
  • For dirty wounds, give booster if >5 years since last dose 1

Common Pitfalls to Avoid

  • Do not use trimethoprim-sulfamethoxazole or doxycycline as monotherapy if beta-hemolytic streptococci are likely, as their activity against streptococci is not well-defined 1
  • Avoid topical antibiotics for anything beyond superficial impetigo with limited lesions—systemic therapy is needed for established infections 1
  • Do not use rifampin as monotherapy due to rapid resistance development 1
  • Linezolid should not be first-line due to cost and lack of superiority over less expensive alternatives 1

Pediatric Dosing

  • Cephalexin: 25-50 mg/kg/day in 4 divided doses (can be given every 12 hours for skin infections) 2
  • Dicloxacillin: 25-50 mg/kg/day in 4 divided doses 1
  • Clindamycin: 20-30 mg/kg/day in 3 divided doses orally 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.